| Effects of Shengmai Yin(生脉饮)on pulmonary and cardiac function in coronavirus disease 2019 convalescent patients with cardiopulmonary symptoms:a randomized,double blind,multicenter control trial |
| |
| 作者姓名： | AN Xuedong MAO Lina XIA Ping SU Wen WANG Beibei KOU Leiya ZHANG Zequan QI Meng HU Song CHEN Jing LI Xiujuan LIU Jinwei ZHOU Juan QIAO Jie LUO Dan LUO Guangwei YAN Youqin YANG Guiping DONG Dandan ZHOU Wei TAO Junxiu JIN De TONG Xiaolin WEI Li |
| |
| 作者单位： | 1. Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences;2. Department of Traditional Chinese Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);3. Department of Orthopedics, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);4. Department of Paediatrics, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);5. Department of Respiratory and Critical Care Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);6. College of Traditional Chinese Medicine,Hubei University of Traditional Chinese Medicine;7. Department of Pharmacy, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);8. Department of Geriatrics, Wuhan No. 1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital);9. Department of Infectious Diseases, Wuhan No.7 Hospital;10. Department of Gastroenterology, Xiaogan Traditional Chinese Medicine Hospital;11. Department of Gastroenterology, Wuhan No.7 Hospital;12. Department of Hepatology, Hubei Provincial Hospital of Traditional Chinese Medicine;13. Institute of Metabolic Diseases, Guang’an Men Hospital of China Academy of Chinese Medical Sciences;14. Department of Critical Care Medicine, Wuhan No.1 Hospital (Wuhan Integrated TCM and Western Medicine Hospital) |
| |
| 摘 要： | OBJECTIVE: To evaluate the efficacy and safety of Shengmai Yin(生脉饮, SMY) on visual analogue scale(VAS) for cardiopulmonary symptoms in coronavirus disease 2019(COVID-19) convalescent patients. METHODS: In this randomized, double blind and multicenter controlled trial, a total of 200 COVID-19 convalescent patients who with cardiopulmonary symptoms were enrolled from three medical centers in Hubei, China. These patients were randomized divided into trial group and the control group, 100 patients i...
|
| 关 键 词： | COVID-19 convalescence visual analog scale cardiopulmonary symptoms Shengmai Yin |
|
|
